Zobair M Younossi (Z Younossi, Z M Younossi, Zobair Younossi)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 155

Top Venues

Alimentary pharmacology & therapeutics

Liver international : official journal of the International Association for the Study of the Liver

Journal of viral hepatitis

Hepatology communications

This page only lists publications with an associated author ORCID identifier.

Publications

Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Stephen Caldwell, Ginger Clark, Jeff Teckman, Veeral H Ajmera, Cynthia Behling, Mark Brantly, David Brenner, Jeanine D'Armiento, Michael W Fried, Janani S Iyer, Mattias Mandorfer, Don C Rockey, Monica A Tincopa, Raj K Vuppalanchi, Zobair M Younossi, Aleksander Krag, Alice M Turner, Pavel Strnad
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease. Alimentary pharmacology & therapeutics 59 (10) (2024)
Pegah Golabi, Soroor Owrangi, Zobair M Younossi
Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies. Alimentary pharmacology & therapeutics (2024)
Stephen Caldwell, Ginger Clark, Jeff Teckman, Veeral H Ajmera, Cynthia Behling, Mark Brantly, David Brenner, Jeanine D'Armiento, Michael W Fried, Janani S Iyer, Mattias Mandorfer, Don C Rockey, Monica A Tincopa, Raj K Vuppalanchi, Zobair M Younossi, Aleksander Krag, Alice M Turner, Pavel Strnad
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease. Alimentary pharmacology & therapeutics 59 (10) (2024)
Faiez Zannad, Arun J Sanyal, Javed Butler, João Pedro Ferreira, Nicolas Girerd, Veronica Miller, Ambarish Pandey, Chirag R Parikh, Vlad Ratziu, Zobair M Younossi, Stephen A Harrison
MASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials. Journal of internal medicine 296 (1) (2024)
Aaron B Koenig, Albert Tan, Hala Abdelaal, Fanny Monge, Zobair M Younossi, Zachary D Goodman
Review article: Hepatic steatosis and its associations with acute and chronic liver diseases. Alimentary pharmacology & therapeutics 60 (2) (2024)
Aaron B Koenig, Albert Tan, Hala Abdelaal, Fanny Monge, Zobair M Younossi, Zachary D Goodman
Review article: Hepatic steatosis and its associations with acute and chronic liver diseases. Alimentary pharmacology & therapeutics (2024)
Zobair M Younossi, Linda Henry
Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action. Diabetes spectrum : a publication of the American Diabetes Association 37 (1) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Saleh A Alqahtani, Yusuf Yilmaz, Mohamed El Kassas, Khalid Alswat, Faisal M Sanai, May AlZahrani, Faisal Abaalkhail, Manal AlShaikh, Waleed K Al-Hamoudi, Fatema Nader, Maria Stepanova, Zobair M Younossi, null null
Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt. Journal of viral hepatitis (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Faiez Zannad, Arun J Sanyal, Javed Butler, João Pedro Ferreira, Nicolas Girerd, Veronica Miller, Ambarish Pandey, Chirag R Parikh, Vlad Ratziu, Zobair M Younossi, Stephen A Harrison
MASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials. Journal of internal medicine (2024)
Stephen Caldwell, Ginger Clark, Jeff Teckman, Veeral H Ajmera, Cynthia Behling, Mark Brantly, David Brenner, Jeanine D'Armiento, Michael W Fried, Janani S Iyer, Mattias Mandorfer, Don C Rockey, Monica A Tincopa, Raj K Vuppalanchi, Zobair M Younossi, Aleksander Krag, Alice M Turner, Pavel Strnad
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease. Alimentary pharmacology & therapeutics 59 (10) (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Aaron B Koenig, Albert Tan, Hala Abdelaal, Fanny Monge, Zobair M Younossi, Zachary D Goodman
Review article: Hepatic steatosis and its associations with acute and chronic liver diseases. Alimentary pharmacology & therapeutics 60 (2) (2024)
Pegah Golabi, Soroor Owrangi, Zobair M Younossi
Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies. Alimentary pharmacology & therapeutics (2024)
James M Paik, Dipam Shah, Katherine Eberly, Pegah Golabi, Linda Henry, Zobair M Younossi
Changes in mortality due to Chronic Liver Diseases (CLD) during the COVID-19 pandemic: Data from the United States' National Vital Statistics System. PloS one 19 (9) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
James M Paik, Dipam Shah, Katherine Eberly, Pegah Golabi, Linda Henry, Zobair M Younossi
Changes in mortality due to Chronic Liver Diseases (CLD) during the COVID-19 pandemic: Data from the United States' National Vital Statistics System. PloS one 19 (9) (2024)
Stephen Caldwell, Ginger Clark, Jeff Teckman, Veeral H Ajmera, Cynthia Behling, Mark Brantly, David Brenner, Jeanine D'Armiento, Michael W Fried, Janani S Iyer, Mattias Mandorfer, Don C Rockey, Monica A Tincopa, Raj K Vuppalanchi, Zobair M Younossi, Aleksander Krag, Alice M Turner, Pavel Strnad
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease. Alimentary pharmacology & therapeutics (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Saleh A Alqahtani, Yusuf Yilmaz, Mohamed El Kassas, Khalid Alswat, Faisal M Sanai, May AlZahrani, Faisal Abaalkhail, Manal AlShaikh, Waleed K Al-Hamoudi, Fatema Nader, Maria Stepanova, Zobair M Younossi, null null
Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt. Journal of viral hepatitis 31 (6) (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver (2024)
Zobair M Younossi, Linda Henry
Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action. Diabetes spectrum : a publication of the American Diabetes Association 37 (1) (2024)
Faiez Zannad, Arun J Sanyal, Javed Butler, João Pedro Ferreira, Nicolas Girerd, Veronica Miller, Ambarish Pandey, Chirag R Parikh, Vlad Ratziu, Zobair M Younossi, Stephen A Harrison
MASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials. Journal of internal medicine 296 (1) (2024)
James M Paik, Dipam Shah, Katherine Eberly, Pegah Golabi, Linda Henry, Zobair M Younossi
Changes in mortality due to Chronic Liver Diseases (CLD) during the COVID-19 pandemic: Data from the United States' National Vital Statistics System. PloS one 19 (9) (2024)
Pegah Golabi, Soroor Owrangi, Zobair M Younossi
Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies. Alimentary pharmacology & therapeutics (2024)
Saleh A Alqahtani, Maria Stepanova, Reem Al Shabeeb, Kathrine Luz Eberly, Janus Ong, Zobair M Younossi
The impact of hepatitis B and C positive serologies on the outcomes of non-hepatic solid organ transplantation in the United States. Journal of viral hepatitis 31 (4) (2023)
Linda Henry, Zobair M Younossi
Letter: should we abandon FIB-4 to characterise noninvasively patients with NAFLD? Authors' reply. Alimentary pharmacology & therapeutics 57 (8) (2023)
Saleh A Alqahtani, Maria Stepanova, Reem Al Shabeeb, Kathrine Luz Eberly, Janus Ong, Zobair M Younossi
The impact of hepatitis B and C positive serologies on the outcomes of non-hepatic solid organ transplantation in the United States. Journal of viral hepatitis 31 (4) (2023)
Zobair M Younossi, Shira Zelber-Sagi, Linda Henry, Lynn H Gerber
Lifestyle interventions in nonalcoholic fatty liver disease. Nature reviews. Gastroenterology & hepatology (2023)
Saleh A Alqahtani, Maria Stepanova, Reem Al Shabeeb, Kathrine Luz Eberly, Janus Ong, Zobair M Younossi
The impact of hepatitis B and C positive serologies on the outcomes of non-hepatic solid organ transplantation in the United States. Journal of viral hepatitis 31 (4) (2023)
Maria Stepanova, Zobair M Younossi
Editorial: optimal combination of non-invasive tests to determine significant fibrosis in non-alcoholic fatty liver disease-authors' reply. Alimentary pharmacology & therapeutics 57 (12) (2023)
Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay K Duseja, Stuart C Gordon, Yuichiro Eguchi, Vasily A Isakov, Stuart Keith Roberts, Jian-Gao Fan, Ashwani K Singal, Manuel Romero-Gómez, Andrew A Li, Janus Ong, Brian P Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani
Clinical and Patient-Reported Outcome Profile of Patients with Hepatitis B Viral Infection from the Global Liver Registry™. Journal of viral hepatitis (2023)
Austin Henry, James M Paik, Patrick Austin, Katherine Elizabeth Eberly, Pegah Golabi, Issah Younossi, Linda Henry, N Lynn Gerber, Zobair M Younossi
Editorial: let's get physical-long-term benefits of vigorous physical activity in patients with nonalcoholic fatty liver disease. Authors' reply. Alimentary pharmacology & therapeutics 57 (6) (2023)
Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay K Duseja, Stuart C Gordon, Yuichiro Eguchi, Vasily A Isakov, Stuart Keith Roberts, Jian-Gao Fan, Ashwani K Singal, Manuel Romero-Gómez, Andrew A Li, Janus Ong, Brian P Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™. Journal of viral hepatitis 30 (4) (2023)
Stephen A Harrison, Vlad Ratziu, Quentin Mark Anstee, Mazen Noureddin, Arun J Sanyal, Jörn Markus Schattenberg, Pierre Bedossa, Mustafa R Bashir, David Schneider, Rebecca Taub, Meena Bansal, Kris V Kowdley, Zobair M Younossi, Rohit Loomba
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2023)
Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay K Duseja, Stuart C Gordon, Yuichiro Eguchi, Vasily A Isakov, Stuart Keith Roberts, Jian-Gao Fan, Ashwani K Singal, Manuel Romero-Gómez, Andrew A Li, Janus Ong, Brian P Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™. Journal of viral hepatitis (2023)
Marcelo Kugelmas, Mazen Noureddin, Nadege Gunn, Kimberly Brown, Zobair M Younossi, Manal Abdelmalek, Naim Alkhouri
The Use of Current Knowledge and Non-Invasive Testing Modalities for Predicting At-Risk Nonalcoholic Steatohepatitis and Assessing Fibrosis. Liver international : official journal of the International Association for the Study of the Liver (2023)
Maria Stepanova, Ameeta Kumar, Pamela Brandt, Nagashree Gundurao, Kenneth Cusi, Saleh Al Qahtani, Zobair M Younossi
Impact of Type 2 Diabetes on the Outcomes of Solid Organ Transplantations in the U.S.: Data From a National Registry. Diabetes care (2023)
Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay K Duseja, Stuart C Gordon, Yuichiro Eguchi, Vasily A Isakov, Stuart Keith Roberts, Jian-Gao Fan, Ashwani K Singal, Manuel Romero-Gómez, Andrew A Li, Janus Ong, Brian P Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™. Journal of viral hepatitis 30 (4) (2023)
Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay K Duseja, Stuart C Gordon, Yuichiro Eguchi, Vasily A Isakov, Stuart Keith Roberts, Jian-Gao Fan, Ashwani K Singal, Manuel Romero-Gómez, Andrew A Li, Janus Ong, Brian P Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™. Journal of viral hepatitis 30 (4) (2023)
Zobair M Younossi, Maria Stepanova, Sean Felix, Thomas Jeffers, Elena Younossi, Zachary Goodman, Andrei Racila, Brian P Lam, Linda Henry
The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease. Alimentary pharmacology & therapeutics (2023)
Saleh A Alqahtani, Maria Stepanova, Reem Al Shabeeb, Kathrine Luz Eberly, Janus Ong, Zobair M Younossi
The impact of hepatitis B and C positive serologies on the outcomes of non-hepatic solid organ transplantation in the United States. Journal of viral hepatitis (2023)
Heiner Wedemeyer, Tammo L Tergast, Jeffrey Victor Lazarus, Homie Razavi, Kostas Bakoyannis, Ricardo Baptista-Leite, Marco Bartoli, Philip Bruggmann, Cristian-Silviu Buşoi, Maria Buti, Manuel Carballo, Laurent Castera, Massimo Colombo, Rodrigo Sousa Coutinho, Yuval Dadon, Gamal Esmat, Rafael Esteban, Joan Colom Farran, Mark Gillyon-Powell, David Goldberg, Sharon Hutchinson, Harry L A Janssen, George Kalamitsis, Loreta A Kondili, John S Lambert, Rui Tato Marinho, Mojca Maticic, Aldo Patricello, Markus Peck-Radosavljevic, Stanislas Pol, Mario Poljak, Cora Pop, Tomislov Sokol, Vana Sypsa, Nurdan Tözün, Zobair M Younossi, Alessio Aghemo, Georgios Papatheodoridis, Angelos Hatzakis
Securing Wider EU Commitment to the Elimination of HCV. Liver international : official journal of the International Association for the Study of the Liver (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Issacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2022)
Yusuf Yilmaz, Zobair M Younossi
Editorial: changes of health-related quality of life associated with hepatic disease severity and its improvement after treatment in NAFLD-authors' reply. Alimentary pharmacology & therapeutics 57 (2) (2022)
Zobair M Younossi, James M Paik, Pegah Golabi, Youssef Younossi, Linda Henry, Fatema Nader
The impact of fatigue on mortality of patients with non-alcoholic fatty liver disease: Data from National Health and nutrition examination survey 2005-2010 and 2017-2018. Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
Austin Henry, James M Paik, Patrick Austin, Katherine Elizabeth Eberly, Pegah Golabi, Issah Younossi, Linda Henry, Lynn Gerber, Zobair M Younossi
Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD). Alimentary pharmacology & therapeutics (2022)
Stephen Caldwell, Daniel Q Huang, Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew Billin, Ryan S Huss, Chuhan Chung, Zachary Goodman, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gómez, Manal F Abdelmalek, Andrew Muir, Nezam Afdhal, Jaime Bosch, Stephen Harrison, Zobair M Younossi, Robert P Myers
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. Gut 72 (3) (2022)
Yusuf Yilmaz, Zobair M Younossi
Editorial: changes of health-related quality of life associated with hepatic disease severity and its improvement after treatment in NAFLD-authors' reply. Alimentary pharmacology & therapeutics 57 (2) (2022)
Zobair M Younossi, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Marlen I Castellanos Fernández, Maria Buti, Georgios Papatheodoridis, Yusuf Yilmaz, Vasily Isakov, Ajay Duseja, Nahum Méndez-Sánchez, Saeed Hamid, Stuart C Gordon, Manuel Romero-Gómez, Wah-Kheong Chan, Janus P Ong, Issah Younossi, Brain Lam, Mariam Ziayee, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova, null null
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry. Journal of viral hepatitis 29 (11) (2022)
Linda Henry, James Paik, Zobair M Younossi
Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world. Alimentary pharmacology & therapeutics 56 (6) (2022)
Rish K Pai, Vipul Jairath, Malcolm Hogan, Guangyong Zou, Oyedele A Adeyi, Quentin Mark Anstee, Bashar A Aqel, Cynthia Behling, Elizabeth J Carey, Andrew D Clouston, Kathleen E Corey, Brian G Feagan, David E Kleiner, Christopher Ma, Stefanie C McFarlane, Mazen Noureddin, Vlad Ratziu, Mark A Valasek, Zobair M Younossi, Stephen A Harrison, Stephen Caldwell
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score. Hepatology (Baltimore, Md.) 76 (4) (2022)
Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Ajay Kumar Duseja, Saeed Hamid, Gamal Esmat, Nahum Méndez-Sánchez, Wah Kheong Chan, Ashwani K Singal, Brian Lam, Sean Felix, Elena Younossi, Manisha Verma, Jillian K Price, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova
The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry. Hepatology communications 6 (10) (2022)
Brian Lam, Maria Stepanova, Chapy Venkatesan, Ivan Garcia, Mary Reyes, Ashiq Mannan, Soleyah Groves, Mehul Desai, Andrei Racila, Andrej Kolacevski, Linda Henry, Lynn H Gerber, Zobair M Younossi
Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system. PloS one 17 (2) (2022)
Zobair M Younossi, James M Paik, Reem Al Shabeeb, Pegah Golabi, Issah Younossi, Linda Henry
Are there outcome differences between NAFLD and metabolic-associated fatty liver disease? Hepatology (Baltimore, Md.) 76 (5) (2022)
Catherine Van Dongen, James M Paik, Michael Harring, Youssef Younossi, Jillian K Price, Khaled Kabbara, Pegah Golabi, Zobair M Younossi
Sarcopenia, healthy living, and mortality in patients with chronic liver diseases. Hepatology communications 6 (11) (2022)
Stephen Caldwell, Daniel Q Huang, Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew Billin, Ryan S Huss, Chuhan Chung, Zachary Goodman, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gómez, Manal F Abdelmalek, Andrew Muir, Nezam Afdhal, Jaime Bosch, Stephen Harrison, Zobair M Younossi, Robert P Myers
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. Gut 72 (3) (2022)
Linda Henry, James M Paik, Zobair M Younossi
Reply. Hepatology (Baltimore, Md.) 76 (5) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Stephen Caldwell, Daniel Q Huang, Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew Billin, Ryan S Huss, Chuhan Chung, Zachary Goodman, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gómez, Manal F Abdelmalek, Andrew Muir, Nezam Afdhal, Jaime Bosch, Stephen Harrison, Zobair M Younossi, Robert P Myers
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. Gut 72 (3) (2022)
Maria Stepanova, Khaled Kabbara, Denise Mohess, Manisha Verma, Alva Roche-Green, Saleh AlQahtani, Janus Ong, Patrizia Burra, Zobair M Younossi
Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients. Hepatology communications 6 (7) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Yusuf Yilmaz, Ahmet Eren Toraman, Ceyda Alp, Zehra Doğan, Caglayan Keklikkiran, Maria Stepanova, Zobair M Younossi
Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study. Alimentary pharmacology & therapeutics (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Stephen Caldwell, Daniel Q Huang, Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew Billin, Ryan S Huss, Chuhan Chung, Zachary Goodman, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gómez, Manal F Abdelmalek, Andrew Muir, Nezam Afdhal, Jaime Bosch, Stephen Harrison, Zobair M Younossi, Robert P Myers
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. Gut 72 (3) (2022)
Khaled Kabarra, Pegah Golabi, Zobair M Younossi
Nonalcoholic steatohepatitis: global impact and clinical consequences. Endocrine connections 10 (10) (2021)
James M Paik, Pegah Golabi, Youssef Younossi, Nazaneen Saleh, Annan Nhyira, Zobair M Younossi
The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007-2017. Hepatology communications 5 (5) (2021)
Zobair M Younossi, Maria Stepanova, Brian Lam, Rebecca Cable, Sean Felix, Thomas Jeffers, Elena Younossi, Huong Pham, Manirath Srishord, Patrick Austin, Michael Estep, Kathy Terra, Carey Escheik, Leyla de Avila, Pegah Golabi, Andrej Kolacevski, Andrei Racila, Linda Henry, Lynn Gerber
Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID-19 Infection. Hepatology communications (2021)
Zobair M Younossi, Mary E Rinella, Arun J Sanyal, Stephen A Harrison, Elizabeth M Brunt, Zachary Goodman, David E Cohen, Rohit Loomba
From NAFLD to MAFLD: Implications of a Premature Change in Terminology. Hepatology (Baltimore, Md.) 73 (3) (2021)
Saleh A Alqahtani, James M Paik, Rakesh Biswas, Tamoore Arshad, Linda Henry, Zobair M Younossi
Poor Awareness of Liver Disease Among Adults With NAFLD in the United States. Hepatology communications 5 (11) (2021)
John Paul Verderese, Maria Stepanova, Brian Lam, Andrei Racila, Andrej Kolacevski, David Allen, Erin Hodson, Bahareh Aslani-Amoli, Michael Homeyer, Sarah Stanmyre, Helen Stevens, Stephanie Garofalo, Linda Henry, Chapy Venkatesan, Lynn H Gerber, Steve Motew, J Stephen Jones, Zobair M Younossi
Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Zobair M Younossi, Maria Stepanova, Mazen Noureddin, Kris V Kowdley, Simone I Strasser, Anita Kohli, Peter Ruane, Mitchell L Shiffman, Aasim Sheikh, Nadege Gunn, Stephen H Caldwell, Ryan S Huss, Robert P Myers, Vincent Wai-Sun Wong, Naim Alkhouri, Zachary Goodman, Rohit Loomba
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis. Hepatology communications 5 (7) (2021)
Joana Vieira Barbosa, Scott Milligan, Andrew Frick, Jeremy Broestl, Zobair M Younossi, Nezam H Afdhal, Michelle Lai
Fibrosis-4 Index as an Independent Predictor of Mortality and Liver-Related Outcomes in NAFLD. Hepatology communications 6 (4) (2021)
John Paul Verderese, Linda Henry, Zobair M Younossi
Reply to Bailly, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Saleh A Alqahtani, Pegah Golabi, James M Paik, Brian Lam, Amir H Moazez, Hazem A Elariny, Zachary Goodman, Zobair M Younossi
Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. Obesity surgery 31 (5) (2021)
James M Paik, Seema Mir, Saleh A Alqahtani, Youssef Younossi, Janus P Ong, Zobair M Younossi
Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data. Hepatology communications (2021)
Tamoore Arshad, James M Paik, Rakesh Biswas, Saleh A Alqahtani, Linda Henry, Zobair M Younossi
Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007-2016. Hepatology communications 5 (10) (2021)
Fasiha Kanwal, Jay H Shubrook, Zobair M Younossi, Yamini Natarajan, Elisabetta Bugianesi, Mary E Rinella, Stephen A Harrison, Christos S Mantzoros, Kim Pfotenhauer, Samuel Klein, Robert H Eckel, Davida Kruger, Hashem El-Serag, Kenneth Cusi
Preparing for the NASH Epidemic: A Call to Action. Diabetes care 44 (9) (2021)
Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Manal F Abdelmalek, Dora Ding, Ling Han, Catherine Jia, Ryan S Huss, Chuhan Chung, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gomez, Andrew J Muir, Nezam H Afdhal, Jaime Bosch, Zachary Goodman, Stephen A Harrison, Zobair M Younossi, Robert P Myers
Cirrhosis Regression is Associated with Improved Clinical Outcomes in Patients with Nonalcoholic Steatohepatitis. Hepatology (Baltimore, Md.) (2021)
James M Paik, Pegah Golabi, Youssef Younossi, Alita Mishra, Zobair M Younossi
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD. Hepatology (Baltimore, Md.) 72 (5) (2020)
Pegah Golabi, James M Paik, Tamoore Arshad, Youssef Younossi, Alita Mishra, Zobair M Younossi
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities. Hepatology communications 4 (8) (2020)
Zobair M Younossi, Kathleen E Corey, Naim Alkhouri, Mazen Noureddin, Ira Jacobson, Brian Lam, Stephen Clement, Rita Basu, Stuart C Gordon, Natarajan Ravendhra, Puneet Puri, Mary Rinella, Peter Scudera, Ashwani K Singal, Linda Henry, null null
Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices. Alimentary pharmacology & therapeutics 52 (3) (2020)
Azza Karrar, Bijal Rajput, Siddharth Hariharan, Dinan Abdelatif, Mohamad Houry, Ali Moosvi, Irfan Ali, Daisong Tan, Sohailla Noor, Donna Esmaeili, Sean Felix, Lakshmi Alaparthi, Munkhzul Otgonsuren, Brian Lam, Zachary D Goodman, Zobair M Younossi
Major Histocompatibility Complex Class I-Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver Disease. Hepatology communications 5 (1) (2020)
Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila
Development and validation of a hepatitis B-specific health-related quality-of-life instrument: CLDQ-HBV. Journal of viral hepatitis 28 (3) (2020)
James M Paik, Pegah Golabi, Rakesh Biswas, Saleh Alqahtani, Chapy Venkatesan, Zobair M Younossi
Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States. Hepatology communications 4 (6) (2020)
James M Paik, Pegah Golabi, Youssef Younossi, Manirath Srishord, Alita Mishra, Zobair M Younossi
The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007-2017. Hepatology communications 4 (12) (2020)
Zobair M Younossi, Vincent Wai-Sun Wong, Quentin Mark Anstee, Manuel Romero, Michael H Trauner, Stephen A Harrison, Eric J Lawitz, Takeshi Okanoue, Marianne Camargo, Kathryn Kersey, Robert P Myers, Zachary Goodman, Maria Stepanova
Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes. Hepatology communications 4 (11) (2020)
Zobair M Younossi, Lind Henry
Letter: the use of Fibrosis-4 score in primary care and diabetology practices-Occam's razor applied to advanced fibrosis screening. Authors' reply. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Elizabeth M Brunt, David E Kleiner, Danielle H Carpenter, Mary Rinella, Stephen A Harrison, Rohit L Loomba, Zobair M Younossi, Brent A Neuschwander-Tetri, Arun J Sanyal, null null
Nonalcoholic fatty liver disease: Reporting histologic findings in clinical practice. Hepatology (Baltimore, Md.) (2020)
Zobair M Younossi, Frank Tacke, Marco Arrese, Barjesh Chander Sharma, Ibrahim Mostafa, Elisabetta Bugianesi, Vincent Wai-Sun Wong, Yusuf Yilmaz, Jacob George, Jiangao Fan, Miriam B Vos
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology (Baltimore, Md.) 69 (6) (2020)
Zobair M Younossi, Linda Henry
Editorial: a diabetologist's perspective on the diagnosis and monitoring of NAFLD-Authors' reply. Alimentary pharmacology & therapeutics 52 (4) (2020)

Zobair M Younossi.css-eqlu8i{font-size:small;padding-left:4px;} (Z Younossi, Z M Younossi, Zobair Younossi)

Publication Activity (10 Years)

Top Topics

Top Venues

Zobair M Younossi (Z Younossi, Z M Younossi, Zobair Younossi)